PulseAugur
LIVE 07:39:26
research · [1 source] · · 中文(ZH) 北陆药业:获得碘佛醇注射液药品注册证书
0
research

Guangzhou AI plan targets computing power and data

Guangzhou has released its 2026 work plan for the AI industry, focusing on strengthening intelligent computing power and data element supply. The plan emphasizes a tiered development of data centers and optimizing construction standards for computing power projects. It also aims to improve data circulation mechanisms, deepen public data resource operation, and foster data sharing and fusion applications to create high-quality multimodal datasets. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

IMPACT This plan signals Guangzhou's strategic commitment to building AI infrastructure and data ecosystems, potentially attracting investment and talent.

RANK_REASON The cluster contains a government policy document outlining strategic development for a major city's AI industry. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on 36氪 (36Kr) →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Beilu Pharmaceutical: Obtains Drug Registration Certificate for Iofetamine Hydrochloride Injection

    36氪获悉,北陆药业公告,公司收到国家药监局核准签发的碘佛醇注射液《药品注册证书》。该药品为化学药品4类,视同通过仿制药一致性评价,适应症包括冠状动脉造影、CT增强扫描等。该产品已被纳入国家医保甲类目录,2023-2025年销售额均超30亿元,在造影剂产品中排名首位。此次获批丰富了公司碘类对比剂产品线,提升了市场竞争力。